Improvement of Lower Digestive Endoscopy Without Anesthesia : Evaluation of the Virtual Reality Mask
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 13, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how using a virtual reality (VR) mask during colonoscopies can help patients feel less pain and anxiety, allowing them to have the procedure without needing general anesthesia (GA). Currently, most colonoscopies are done with GA, which involves more risks and requires extra planning. By testing the VR mask, researchers hope to make the experience more comfortable for patients, potentially leading to more successful colonoscopies without GA and reducing the need for rescheduling.
To be eligible for this trial, participants must be over 18 years old and need a colonoscopy without GA. However, those with certain conditions, like hearing or vision problems, psychiatric issues, or a history of seizures or claustrophobia, cannot participate. If you join the study, you can expect to wear a VR mask during your procedure, which may help you feel more relaxed. This trial is not yet recruiting participants, but it aims to provide valuable insights into improving patient comfort during colonoscopies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 years old with an indication for total colonoscopy and accepting without General Anesthesia
- Exclusion Criteria:
- • Hearing problems or low vision
- • Psychiatric or cognitive disorders hindering communication
- • History of epilepsy
- • Claustrophobia which can lead to a rejection of the virtual reality mask
- • History of cybercynetosis during previous use of VR
- • Chronic abdominal pain with baseline Visual analogue scale (VAS) \> 5
- • Emergency examination
- • Patient participating in another interventional research on digestive endoscopy
- • Patient not speaking French
- • Patient under guardianship
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported